Ivus-F 10 Tablet is a combination lipid-lowering agent containing Fenofibrate 160 mg and Rosuvastatin 10 mg, indicated for the management of dyslipidemia and mixed hyperlipidemia. Fenofibrate, a fibric acid derivative, primarily reduces elevated triglycerides and increases high-density lipoprotein cholesterol (HDL-C), while Rosuvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) and total cholesterol levels. The synergistic action of these agents helps in achieving comprehensive lipid control, thereby reducing the risk of cardiovascular events in patients with atherogenic dyslipidemia. Ivus-F 10 is prescribed as an adjunct to diet and lifestyle modifications in patients who have not achieved adequate lipid control with monotherapy. It is particularly beneficial in individuals with mixed dyslipidemia characterized by elevated triglycerides and LDL cholesterol. The combination should be used cautiously in patients with hepatic or renal impairment and is contraindicated in active liver disease or unexplained persistent elevations of serum transaminases. Regular monitoring of liver function tests, renal parameters, and lipid profile is recommended during therapy. Ivus-F 10 Tablet offers an effective therapeutic option for comprehensive lipid management under medical supervision.